Early Imaging Biomarkers in NSCLC
Early Imaging Biomarkers to Predict Radiation-Induced Cardiopulmonary Toxicity in Patients With Thoracic Malignancies
Sponsor: Department of Health and Human Services
This observational or N/A phase trial investigates Thoracic Cancer and is currently completed. Department of Health and Human Services leads this study, which shows 8 recorded versions since 2015 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Sep 2019 — Jan 2021 [monthly]
Completed
Status: Active Not Recruiting → Completed · Phase: NA → None
-
Feb 2019 — Sep 2019 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
▶ Show 3 earlier versions
-
Nov 2018 — Feb 2019 [monthly]
Recruiting NA
-
Jun 2018 — Nov 2018 [monthly]
Recruiting NA
-
Jun 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
Sep 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Department of Health and Human Services
- University of Michigan Rogel Cancer Center
For direct contact, visit the study record on ClinicalTrials.gov .